Urinary cystatin B differentiates progressive versus stable IRIS Stage 1 chronic kidney disease in dogs.
Segev G, Vaden S, Ross S, Dufayet C, Cohn LA, Farace G, Szlosek D, Ouyang Z, Peterson S, Beall M, Yerramilli M, Polzin D, Cowgill LD.
J Vet Intern Med. 2023 Nov-Dec;37(6):2251-2260. doi: 10.1111/jvim.16887. Epub 2023 Oct 10.
Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).
Hwang JW, Kim DG, Kim H, Kwak JJ, Cho SW, Bae DM, Shin YC, Doh JH, Kwon SU, Namgung J, Lee SY.
Clin Cardiol. 2022 Apr;45(4):391-400. doi: 10.1002/clc.23792. Epub 2022 Feb 16.
Apolipoproteins A and B and PCSK9: Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease and in End-Stage Renal Disease.
Vlad CE, Foia L, Popescu R, Ivanov I, Luca MC, Delianu C, Toma V, Statescu C, Rezus C, Florea L.
J Diabetes Res. 2019 Dec 14;2019:6906278. doi: 10.1155/2019/6906278. eCollection 2019.
Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.
DaRoza G, Loewen A, Djurdjev O, Love J, Kempston C, Burnett S, Kiaii M, Taylor PA, Levin A.
Am J Kidney Dis. 2003 Dec;42(6):1184-92. doi: 10.1053/j.ajkd.2003.08.019.
A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
Krairittichai U, Sethakarun S.
J Med Assoc Thai. 2017 Feb;100 Suppl 1:S1-7.
Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey.
Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME, Goral V.
Intervirology. 2007;50(2):133-7. doi: 10.1159/000098239. Epub 2006 Dec 22.
B-type natriuretic peptide predicts an ischemic etiology of acute heart failure in patients with stage 4-5 chronic kidney disease.
Kim SE, Park S, Kim JK, Kim SG, Kim HJ, Song YR.
Clin Biochem. 2014 Apr;47(6):344-8. doi: 10.1016/j.clinbiochem.2014.01.025. Epub 2014 Jan 31.
Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease.
Niizuma S, Iwanaga Y, Yahata T, Tamaki Y, Goto Y, Nakahama H, Miyazaki S.
Clin Chem. 2009 Jul;55(7):1347-53. doi: 10.1373/clinchem.2008.121236. Epub 2009 May 21.
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18.
